Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 27, 2026 06:31 ET | Source: LLeida.net

Checkpoint Partners Rates Lleida.net a Buy at 3.50 Euros per Share

Madrid, March 27, 2026.- Checkpoint Partners has published an analyst report on Lleida.net (BME:LLN) (EPA:ALLLN) with a Buy recommendation and a target price of 3.50 euros per share on a 12-month...
March 27, 2026 06:00 ET | Source: Li Auto Inc.

Li Auto Inc. Announces Put Right Notification for 0.25% Convertible Senior Notes due 2028

BEIJING, China, March 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it is...
March 27, 2026 05:05 ET | Source: Broad Arrow Auctions

BROAD ARROW PRESENTS RARE OPPORTUNITY TO ACQUIRE FERRARI MONZA SP2 AT CONCORSO D’ELEGANZA VILLA D’ESTE AUCTION

BICESTER, United Kingdom, March 27, 2026 (GLOBE NEWSWIRE) -- Broad Arrow Auctions, driven by Hagerty (NYSE: HGTY), is extremely proud to present a superb, low mileage example of the rarely offered...
March 27, 2026 05:00 ET | Source: GENENTA SCIENCE SPA

Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs

Genenta has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
March 27, 2026 04:00 ET | Source: Geotab Inc.

Geotab’s 2025 Sustainability and Impact Report shows fleets cutting fuel waste, reducing idling by up to 30%, and electrifying as energy costs rise

LONDON and DUBLIN, March 27, 2026 (GLOBE NEWSWIRE) -- As rising fuel prices and ongoing energy volatility puts pressure on margins, businesses are turning to data driven strategies to improve...
March 27, 2026 02:05 ET | Source: Excellergy, Inc.

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
March 27, 2026 02:00 ET | Source: Pharming Group N.V.

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

Pharming announces positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older
March 27, 2026 01:40 ET | Source: MidPoint Capital Partners, LLC

MidPoint Capital Partners, LLC Announces $500 Million Private Real Estate Lending Fund

PHOENIX, March 27, 2026 (GLOBE NEWSWIRE) -- MidPoint Capital Partners, LLC announced the launch of a $500 million private real estate lending fund, MidPoint Capital, LLC, designed to provide...
March 27, 2026 00:12 ET | Source: Zenas BioPharma

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
March 26, 2026 22:54 ET | Source: Gelatine Sculpt

Gelatine Sculpt Claims Evaluated: Documenting the Gelatin Trick Recipe Investigation for Consumer Safety

Gelatine Sculpt gelatin trick recipe claims, bariatric jelly terminology, GLP-1 marketing references, ingredient disclosure, and label verification.